Effects of Intermittent Fasting on Response to Tyrosine Kinase Inhibitors (TKIs) in Patients With Chronic Myeloid Leukemia: An Outcome of European LeukemiaNet Project

The overall survival of patients with Chronic Myeloid Leukemia (CML) treated by using tyrosine kinase inhibitors (TKIs) is very close to that of the healthy population. However, little is known about the effect of specific measures such as intermittent fasting, especially during Ramadan period. A 3-...

Descripción completa

Detalles Bibliográficos
Autores principales: Yassin, Mohamed A., Ghasoub, Rola S., Aldapt, Mahmood B., Abdulla, Mohammad A., Chandra, Prem, Shwaylia, Hawraa M., Nashwan, Abdulqadir J., Kassem, Nancy A., Akiki, Susanna J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204644/
https://www.ncbi.nlm.nih.gov/pubmed/33874754
http://dx.doi.org/10.1177/10732748211009256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204644/
https://www.ncbi.nlm.nih.gov/pubmed/33874754
http://dx.doi.org/10.1177/10732748211009256

Ejemplares similares